Table 4 Cross-tabulation Analysis between Financial Status and management provided
|  | INSURED NON-INSURED n = 24 n = 99 | p- value | |
|---|---|---|---|
ED Management | |||
 Intravenous fluid | 18 (75.0%) | 70 (70.7%) | 0.676 |
 Octreotide | 4 (16.7%) | 19 (19.2%) | 0.776 |
 Tranexamic acid | 2 (8.3%) | 23 (23.2%) | 0.104 |
 PPI | 15 (62.5%) | 73 (73.7%) | 0.274 |
 Antibiotics | 12 (50.0%) | 31 (31.3%) | 0.085 |
 Blood Transfusion | 9 (37.5%) | 51 (51.5%) | 0.218 |
Receiving Endoscopy | 9 (37.5%) | 37 (37.4%) | 0.991 |